The top drugs that could be impacted by an obscure provision in the pandemic relief law

Medicaid could receive larger rebates from drugmakers beginning in 2024 under legislation signed Thursday by President Joe Biden — so large that some pharmaceutical companies could essentially end up paying states to use their drugs.

The provision is tucked into the massive $1.9 trillion pandemic relief package and eliminates what's known as the Medicaid "penny rule."